Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
Open Access
- 6 May 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Rheumatology
- Vol. 17 (1), 20
- https://doi.org/10.1186/s12969-019-0321-x
Abstract
This study aims to describe current practice in identifying and measuring health care resource use and unit costs in economic evaluations or costing studies of juvenile idiopathic arthritis (JIA). A scoping review was conducted (in July 2018) in PubMed and Embase to identify economic evaluations, costing studies, or resource utilization studies focusing on patients with JIA. Only English language peer-reviewed articles reporting primary research were included. Data from all included full-text articles were extracted and analysed to identify the reported health care resource use items. In addition, the data sources used to obtain these resource use and unit costs were identified for all included articles. Of 1176 unique citations identified by the search, 20 full-text articles were included. These involved 4 full economic evaluations, 5 cost-outcome descriptions, 8 cost descriptions, and 3 articles reporting only resource use. The most commonly reported health care resource use items involved medication (80%), outpatient and inpatient hospital visits (80%), laboratory tests (70%), medical professional visits (70%) and other medical visits (65%). Productivity losses of caregivers were much more often incorporated than (future) productivity losses of patients (i.e. 55% vs. 15%). Family borne costs were not commonly captured (ranging from 15% for school costs to 50% for transportation costs). Resource use was mostly obtained from family self-reported questionnaires. Estimates of unit costs were mostly based on reimbursement claims, administrative data, or literature. Despite some consistency in commonly included health care resource use items, variability remains in including productivity losses, missed school days and family borne costs. As these items likely substantially influence the full cost impact of JIA, the heterogeneity found between the items reported in the included studies limits the comparability of the results. Therefore, standardization of resource use items and unit costs to be collected is required. This standardization will provide guidance to future research and thereby improve the quality and comparability of economic evaluations or costing studies in JIA and potentially other childhood diseases. This would allow better understanding of the burden of JIA, and to estimate how it varies across health care systems.Keywords
Funding Information
- Canadian Institutes of Health Research (381280)
- Genome Canada
- ZonMw
- Reumafonds
This publication has 45 references indexed in Scilit:
- The financial burden of juvenile idiopathic arthritis: a Nova Scotia experiencePediatric Rheumatology, 2013
- Impact of juvenile idiopathic arthritis on schoolingBMC Pediatrics, 2013
- 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic FeaturesArthritis Care & Research, 2011
- An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children registerRheumatology, 2011
- Cost‐effectiveness of biologics in polyarticular‐course juvenile idiopathic arthritis patients unresponsive to disease‐modifying antirheumatic drugsArthritis Care & Research, 2010
- Burden of childhood-onset arthritisPediatric Rheumatology, 2010
- Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part IIValue in Health, 2010
- Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritisComplementary Therapies in Medicine, 2009
- Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosisRheumatology, 2008
- Economic impact of juvenile idiopathic arthritisArthritis Care & Research, 2007